Date | Open(₹) | High(₹) | Low(₹) | Close(₹) | No. Of Trades(₹) | Total Turnover(₹) | Deliverable Quantity(₹) |
|---|---|---|---|---|---|---|---|
17-Feb-2025 | 947.75 | 1,019 | 947.75 | 995.45 | 1,03,542 | 1,12,94,07,628.5 | 1,81,797 |
18-Feb-2025 | 995 | 1,034.5 | 943.15 | 1,002.55 | 56,379 | 52,47,79,332.95 | 1,50,421 |
19-Feb-2025 | 990 | 1,008 | 945.5 | 968.45 | 30,069 | 25,89,69,034.6 | 77,940 |
20-Feb-2025 | 960.1 | 1,004.45 | 959.3 | 991.05 | 17,854 | 13,79,03,375.75 | 36,165 |
21-Feb-2025 | 980 | 1,011.5 | 961.05 | 966.95 | 17,436 | 14,00,94,696.75 | 48,543 |
24-Feb-2025 | 958.9 | 969.7 | 932 | 937.65 | 17,879 | 15,83,04,363.8 | 67,254 |
25-Feb-2025 | 947 | 960.85 | 923.2 | 938.5 | 22,411 | 24,05,43,828.1 | 88,758 |
27-Feb-2025 | 935.1 | 948.45 | 902.6 | 909.65 | 28,145 | 22,11,46,397.05 | 1,22,233 |
28-Feb-2025 | 899.9 | 917.5 | 878.05 | 902.7 | 26,408 | 21,31,12,980.2 | 1,08,291 |
03-Mar-2025 | 904.95 | 917.75 | 882.3 | 899.2 | 24,387 | 19,95,27,473.5 | 1,07,297 |
04-Mar-2025 | 883.05 | 928.85 | 881.7 | 920.2 | 14,556 | 10,86,66,308.75 | 43,874 |
05-Mar-2025 | 918 | 927 | 890 | 895.85 | 24,699 | 19,66,53,704.1 | 77,363 |
06-Mar-2025 | 902.05 | 925 | 897.05 | 919.95 | 22,336 | 24,33,76,176.2 | 1,34,212 |
07-Mar-2025 | 923 | 940 | 907 | 910.1 | 25,697 | 16,94,26,290.1 | 87,184 |
10-Mar-2025 | 896.8 | 927.9 | 876.85 | 882.8 | 28,087 | 21,57,45,958.25 | 1,19,144 |
11-Mar-2025 | 879.75 | 901.95 | 867.6 | 890.85 | 29,116 | 14,04,83,763.65 | 70,733 |
12-Mar-2025 | 890 | 891 | 851 | 865 | 23,810 | 19,76,70,162.8 | 1,06,629 |
13-Mar-2025 | 885.85 | 895 | 855 | 866.45 | 47,139 | 51,63,43,253.75 | 1,94,600 |
17-Mar-2025 | 866.4 | 871 | 845.8 | 856.2 | 19,109 | 17,35,78,919.15 | 1,03,277 |
This FDA audit confirms compliance with regulatory standards, enhancing the credibility of Jubilant's operations in the United States.
Jubilant Pharmova Ltd has gained a total of 126% in the last one year, and almost 75% gain since the beginning of the year.
Here are some of the stocks that may see significant price movement today: Tata Motors, Reliance Industries, IREDA, etc.
Drug company Jubilant Pharmova Ltd will acquire an 80% stake in Pierre Fabre Laboratories' Research & Development Centre in Saint Julien, France.
Invest wise with Expert advice
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Securities Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
